Latest Profit Guidance News

Nick Scali Limited has upgraded its first half FY26 revenue and profit guidance, citing stronger than expected sales growth in Australia and New Zealand.

Cedar Woods Properties has raised its FY26 net profit guidance to at least 20% growth, driven by strong sales and faster project delivery, setting the stage for record earnings and higher dividends.

Flight Centre Travel Group has agreed to acquire UK online cruise leader Iglu for £122 million, boosting its cruise sector footprint and upgrading FY26 profit guidance. The deal promises immediate earnings accretion and strategic expansion into key global markets.

Collins Foods has reported record half-year results driven by strong revenue growth, margin expansion, and operational excellence across its Australian and European markets. The company also raised its profit guidance and declared a higher interim dividend.

AUB Group has ended acquisition talks with EQT and CVC after the consortium declined to proceed with a $45 per share offer. The company reaffirms its FY26 earnings guidance and signals confidence in its organic growth strategy.

K&S Corporation has issued a cautious earnings update, forecasting a significant decline in underlying profit before tax for the first half of 2025 compared to last year.

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

FSA Group Ltd reports robust growth in loan origination and loan pools, driven by car loans and asset finance, while raising profit guidance for FY2026. The company’s strategic focus on automation and offshore expansion underpins its ambitious $1.3 billion loan pool target.

Monash IVF Group reported a 6.7% revenue increase to $271.9 million for FY25, alongside an 8.1% decline in underlying NPAT, aligning with prior guidance. The company outlined a cautious FY26 outlook focused on innovation, doctor retention, and cost management.

Monash IVF Group reported solid FY25 revenue and EBITDA growth despite sector softness and clinical incidents, while announcing a leadership transition and dividend pause.

Peet Limited forecasts a robust FY26 with net profit after tax expected between $74 million and $78 million, signaling a 26% to 34% increase over the previous year amid strong market demand and operational momentum.

AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.